RSC Medicinal Chemistry

Papers
(The H4-Index of RSC Medicinal Chemistry is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents105
Back cover102
Back cover102
Inside front cover98
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections88
N-Arylsulfonamide-based adenosine analogues to target RNA cap N7-methyltransferase nsp14 of SARS-CoV-283
Unusual Ni⋯Ni interaction in Ni(ii) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs72
Synthesis and biological evaluation of novel D-ring fused steroidal N(2)-substituted-1,2,3-triazoles70
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold69
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibition67
Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies66
New azole derivatives linked to indole/indoline moieties combined with FLC against drug-resistant Candida albicans54
Emerging Cellular Uptake Mechanisms of bRo5 PROTACs43
Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy42
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking41
ATP-competitive inhibitors for cancer treatment – kinases and the world beyond39
Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure38
Designing halogen-free metal–phenolic imidazolium poly(ionic liquids) with multi-functional antibacterial, anti-inflammatory and cell proliferation properties for infected wounds37
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer37
Integrated computational screen and validation of thalidomide-based PROTACs targeting SARS-CoV-2 main protease37
In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape35
Oxadiargyl analogs as potent inhibitors of Toxoplasma gondii protoporphyrinogen oxidase35
Design, synthesis and structure–activity relationship analysis of dibenzodiazepinone derivatives against Osimertinib resistant NSCLC35
Design, synthesis, in vitro and in silico evaluation of indole-based tetrazole derivatives as putative anti-breast cancer agents31
The effects of bioisostere substitution on the antimicrobial and physicochemical properties of supramolecular self-associating amphiphiles30
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery28
Biocompatible glycolipid derived from bhilawanol as an antibiofilm agent and a promising platform for drug delivery28
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators28
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation28
0.064132928848267